Rathbones Group PLC Has $26.02 Million Stake in Axon Enterprise, Inc $AXON

Rathbones Group PLC raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 40.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 45,808 shares of the biotechnology company’s stock after buying an additional 13,078 shares during the period. Rathbones Group PLC’s holdings in Axon Enterprise were worth $26,016,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth approximately $29,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter worth approximately $37,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth approximately $34,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $28,000. Finally, Sound Income Strategies LLC increased its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Zacks Research upgraded Axon Enterprise from “hold” to “strong-buy,” signaling improved analyst confidence in the stock’s outlook. Zacks.com
• Positive Sentiment: Coverage highlighted strong momentum in Axon’s Connected Devices business, with demand for TASERs, body cameras, and counter-drone products supporting revenue growth and suggesting the core business remains healthy. Zacks article
• Positive Sentiment: Axon said its AI video tools helped HoneyBaked generate eight-figure operational gains, reinforcing the company’s push to expand its software and AI platform beyond hardware. Seeking Alpha article
• Neutral Sentiment: Several recent articles focused on Axon’s long-term valuation after a sharp pullback, noting that the stock remains down significantly year to date even though the company still has strong longer-term growth credentials. Yahoo Finance article
• Neutral Sentiment: Jim Cramer’s comments that the market may not favor high-multiple stocks like Axon right now are more of a macro/valuation caution than a company-specific negative. Yahoo Finance article
• Neutral Sentiment: Market commentary noted Axon has sometimes lagged peers despite daily gains, indicating the stock is still navigating choppy sentiment rather than reacting to a clear business setback. MarketWatch article

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the sale, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. This represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 157 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at $567,910. This represents a 11.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 13,855 shares of company stock valued at $7,109,828 over the last three months. Insiders own 4.20% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AXON. Morgan Stanley set a $600.00 price objective on shares of Axon Enterprise in a report on Thursday, May 7th. Barclays dropped their price objective on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Piper Sandler dropped their price objective on shares of Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a report on Thursday, May 7th. Weiss Ratings raised shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Finally, Citizens Jmp decreased their price target on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise Price Performance

AXON opened at $389.84 on Friday. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The company’s 50 day simple moving average is $419.15 and its 200-day simple moving average is $503.93. The stock has a market capitalization of $31.42 billion, a P/E ratio of 156.56, a price-to-earnings-growth ratio of 7.24 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. During the same period in the prior year, the firm earned $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. Sell-side analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.